AUPHAurinia Pharmaceuticals Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $16.07 (+3.01% today)

Market Cap: $2.08B

P/E (TTM): 7.30

Forward P/E (FY1): 19.80

EPS Growth: 30.1%

Relative Strength (RS%): 92

-2.8% from 52-week high

CANSLIM: Passes criteria

Back to Scanner

AUPH

NASDAQCANSLIMRS 92Score 71

Aurinia Pharmaceuticals Inc.

HealthcareBiotechnology$2.08B6 setups passing
$16.07
+3.0% ($0.47)
-2.8% from 52W High
P/E (TTM)
7.30
Fwd P/E
19.80
PEG
Analyst Upside
EPS Growth
30.1%
Gross Margin
88.5%
ROE
70.4%
D/E
0.13
Div Yield
0.0%
Avg Volume
1.3M

Price Chart

Key Levels

SMA 200
$13.01
SMA 50
$14.51
Price
$16.07
52W High
$16.53

Setup Radar

6/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst